Legal scholars warned officials in Utah that using race to determine which patients could get crucial COVID-19 drugs was likely illegal, but the state kept the system in place for months afterward, newly released emails show.
Utah was one of multiple states to develop systems that gave people who weren’t white a better chance of getting monoclonal antibodies, a crucial treatment for COVID-19, in 2020 and 2021.
